The twins who unlocked the secrets of leukaemia

British girls are behind dramatic breakthrough in medicine

A study of these identical twin girls has led to a new understanding of the causes of childhood leukaemia and could revolutionise the treatment – and possibly prevention – of the potentially lethal disease. The detailed investigation of the two British girls has, for the first time, enabled medical researchers to track down the source of the cancerous stem cells in the blood that can lead to leukaemia in the first few years of life.

Olivia and Isabella Murphy, aged four, from Bromley in Kent, have provided science with an astonishing insight into the nature of leukaemia because of the highly unusual situation where both of them are at risk of the disease but only Olivia developed it.

Scientists believe the findings will enable them to develop better treatments with fewer and less serious side effects. It could also help in the search for the ultimate cause of the condition, which is newly diagnosed in 500 children each year in Britain.

Olivia and Isabella share the same genetic mutation to the blood-forming cells of the bone marrow, which must have occurred during their time in the womb because neither of their parents was found to have the same mutation.

However, only Olivia went on to develop leukaemia because she was unfortunate enough to have suffered a second mutation after birth, which triggered the onset of the cancer.

Scientists believe the mutation in the womb – which occurred in one of the foetuses but was passed to the other via circulating blood cells – caused both girls to be born with pre-cancerous stem cells in their blood, which predisposed them to leukaemia.

However, Olivia suffered the critical second mutation after the twins were born. That led to the development of the full-blown blood cancer which had to be treated with chemotherapy drugs that stunted her growth and led to a serious eye infection.

It was that difference between the two girls that enabled the scientists to locate the pre-cancerous stem cells in both children and then to figure out the sequence of genetic mutations.

Isolating the pre-cancerous stem cells from Olivia and Isabella, who will be five next month, could prove pivotal in the further understanding and treatment of childhood leukaemia, said Professor Mel Greaves of the Institute of Cancer Research in Sutton, Surrey.

"We suspect that these cells can escape conventional chemotherapy and cause relapse during or after treatment. These are the cells that dictate disease course and provide the bull's eye to target with new therapies," he said.

Olivia has successfully undergone treatment for leukaemia and is in remission. However, she is blind in one eye caused by an infection after her time on chemotherapy, which affected her immune system.

Her mother, Sarah, 35, said Olivia's treatment had affected her growth and her hair had become curly, but it had at least cleared many of the pre-cancerous blood cells identified by the research team.

She said she was worried about Isabella."Olivia is almost clear but ... Isabella still has a long way to go. They said the cells might die off naturally but obviously it is something which is hanging over us," Mrs Murphy said.

"It is quite hard but we have always tried to remain positive, although that is easy to say. It would be very hard to have to get through it twice but we are trying not to think about it too much."

Professor Greaves, whose study with Professor Tariq Enver of the Medical Research Council's Weatherall Institute for Molecular Medicine at Oxford University is published in the journal Science, said the genetic mutation found in the pre-cancerous stem cells of the twins was caused by the merging of two genes known as TEL and AML-1.

When the scientists inserted the hybrid TEL-AML-1 gene into human umbilical cord cells and inserted those mutated cells into mice, the mutated cells became self-renewing with the animals' bone marrow, just like they are in children such as Olivia and Isabella.

"This research means we can now test whether the treatment of acute lymphoblastic leukaemia in children can be correlated with either the disappearance or persistence of the leukaemia stem cells," said Professor Enver of Oxford University. "Our next goal is to target both the pre-leukaemic stem cell and the cancer stem cell itself with new or existing drugs to cure leukaemia while avoiding the debilitating and often harmful side effects of current treatments."

Bruce Morland, a childhood cancer specialist at Birmingham Children's Hospital, said the study brought scientists one step closer to the "holy grail" of identifying leukaemic stem cells.

"By determining the characteristics of the leukaemic stem cells it is ultimately the hope of clinicians that therapies can be specifically targeted to the leukaemia, thus sparing the patient from some of the significant side effects of conventional chemotherapy treatment," he said.

Most common childhood cancer

500 new cases of childhood leukaemia in UK per year

1 in 3 of all cancer cases among children is leukaemia

50 percentage of all cases affecting under-five age group

80% survival rate of commonest form (acute lymphoblastic leukaemia)

55% cure rate for acute myeloid leukaemia (which accounts for 1 in 4 cases)

1 in 10 survival rate in the 1960s

0 survival rate pre-1960s

1.4% rise in in childhood lymphoid leukaemia cases in Europe from 1970 to 1999

45.6 per million number of cases among black children in the US during the 1980s and 1990s

27.8 per million number of cases among white children in the same period

50 per million number of cases among Hispanics living in California


Life and Style
ebookNow available in paperback
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Joinery Shop Foreman

    Negotiable: Recruitment Genius: A Joinery Shop Foreman is required to join a p...

    Recruitment Genius: Bench Joiner

    Negotiable: Recruitment Genius: A Bench Joiner is required to join a privately...

    SThree: Trainee Recruitment Consultant - Manchester

    £18000 - £23000 per annum + OTE: SThree: Recruitment and Sales People wanted f...

    Recruitment Genius: Multi Skilled Engineer - Electrical / Mechanical / Maintenance

    £20000 - £30000 per annum: Recruitment Genius: A multi-skilled engineer with a...

    Day In a Page

    Blundering Tony Blair quits as Middle East peace envoy – only Israel will miss him

    Blundering Blair quits as Middle East peace envoy – only Israel will miss him

    For Arabs – and for Britons who lost their loved ones in his shambolic war in Iraq – his appointment was an insult, says Robert Fisk
    Fifa corruption arrests: All hail the Feds for riding to football's rescue

    Fifa corruption arrests

    All hail the Feds for riding to football's rescue, says Ian Herbert
    Isis in Syria: The Kurdish enclave still resisting the tyranny of President Assad and militant fighters

    The Kurdish enclave still resisting the tyranny of Assad and Isis

    In Syrian Kurdish cantons along the Turkish border, the progressive aims of the 2011 uprising are being enacted despite the war. Patrick Cockburn returns to Amuda
    How I survived Cambodia's Killing Fields: Acclaimed surgeon SreyRam Kuy celebrates her mother's determination to escape the US

    How I survived Cambodia's Killing Fields

    Acclaimed surgeon SreyRam Kuy celebrates her mother's determination to escape to the US
    Stephen Mangan interview: From posh buffoon to pregnant dad, the actor has quite a range

    How Stephen Mangan got his range

    Posh buffoon, hapless writer, pregnant dad - Mangan is certainly a versatile actor
    The ZX Spectrum has been crowd-funded back into play - with some 21st-century tweaks

    The ZX Spectrum is back

    The ZX Spectrum was the original - and for some players, still the best. David Crookes meets the fans who've kept the games' flames lit
    Grace of Monaco film panned: even the screenwriter pours scorn on biopic starring Nicole Kidman

    Even the screenwriter pours scorn on Grace of Monaco biopic

    The critics had a field day after last year's premiere, but the savaging goes on
    Menstrual Hygiene Day: The strange ideas people used to believe about periods

    Menstrual Hygiene Day: The strange ideas people once had about periods

    If one was missed, vomiting blood was seen as a viable alternative
    The best work perks: From free travel cards to making dreams come true (really)

    The quirks of work perks

    From free travel cards to making dreams come true (really)
    Is bridge the latest twee pastime to get hip?

    Is bridge becoming hip?

    The number of young players has trebled in the past year. Gillian Orr discovers if this old game has new tricks
    Long author-lists on research papers are threatening the academic work system

    The rise of 'hyperauthorship'

    Now that academic papers are written by thousands (yes, thousands) of contributors, it's getting hard to tell workers from shirkers
    The rise of Lego Clubs: How toys are helping children struggling with social interaction to build better relationships

    The rise of Lego Clubs

    How toys are helping children struggling with social interaction to build better relationships
    5 best running glasses

    On your marks: 5 best running glasses

    Whether you’re pounding pavements, parks or hill passes, keep your eyes protected in all weathers
    Joe Root: 'Ben Stokes gives everything – he’s rubbing off on us all'

    'Ben Stokes gives everything – he’s rubbing off on us all'

    Joe Root says the England dressing room is a happy place again – and Stokes is the catalyst
    Raif Badawi: Wife pleads for fresh EU help as Saudi blogger's health worsens

    Please save my husband

    As the health of blogger Raif Badawi worsens in prison, his wife urges EU governments to put pressure on the Saudi Arabian royal family to allow her husband to join his family in Canada